Project team
State-of-the-art IGL production facility designed for the pharmaceutical and dairy industries, adhering to Q7A Good Manufacturing Practice and building code standards, featuring distinct functional areas and accredited by the United States FDA.
The IGL production facility is a specialty pharmaceutical and dairy industry manufacturing plant, designed in accordance with Q7A Good Manufacturing Practice Guidance for active pharmaceutical ingredients, as well as building code and dairy industry standards. The 3,250 sqm facility includes a variety of distinct areas as part of the process, service and support requirements of the building. Overall the building has rationalised the complicated special relationships required within, by providing a variety of forms for the differing functional areas, and has provided human scale and visual interest to an otherwise utilitarian building. The facility was evaluated and accredited on completion, by the United States FDA.
Like this Project?
Hire DLA Architects
Professional Reviews
Professionals used in
this project
The practices and trades credited on this project.
More projects from
DLA Architects
Other work by DLA Architects, across every category they build in.
More in
Factories and Warehouses
Everything else in Factories and Warehouses, from every practice on ArchiPro.
Next Project
Keep scrolling